Paper40971981
Analysis of global, regional and national trends in the burden of soft tissue and other extraosseous sarcomas from 1990 to 2021: A systematic analysis of the global burden of disease study 2021.
Chen X and 4 others. PLoS One, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Analysis of global, regional and national trends in the burden of soft tissue and other extraosseous sarcomas from 1990 to 2021: A systematic analysis of the global burden of disease study 2021. Papers, record 40971981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40971981
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of global, regional and national trends in the burden of soft tissue and other extraosseous sarcomas from 1990 to 2021: A systematic analysis of the global burden of disease study 2021.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sarcoma | Major topic |
| Global Burden of Disease | Major topic |
| Soft Tissue Neoplasms | Major topic |
| Humans | |
| Male | |
| Female | |
| Incidence | |
| Middle Aged | |
| Adult | |
| Disability-Adjusted Life Years | |
| Adolescent | |
| Aged | |
| Child | |
| Young Adult | |
| Child, Preschool | |
| Global Health | |
| Infant |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38821406 | 99mTc-MDP bone scintigraphy and 18F-FDG PET/CT findings of osteosarcoma with widespread calcified extraskeletal metastases. | Rev Esp Med Nucl Imagen Mol (Engl Ed) | 2024 | https://conductscience.org/library/papers/38821406 | PubMed |
| 2 | 34819142 | Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019. | Mil Med Res | 2021 | https://conductscience.org/library/papers/34819142 | PubMed |
| 3 | 40034600 | Epidemiological trends and age-period-cohort effects on lip and oral cavity cancer burden across the BRICS from 1992 to 2021. | Front Oncol | 2025 | https://conductscience.org/library/papers/40034600 | PubMed |
| 4 | 35410227 | Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data. | Respir Res | 2022 | https://conductscience.org/library/papers/35410227 | PubMed |
| 5 | 39855015 | Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021. | Neoplasia | 2025 | https://conductscience.org/library/papers/39855015 | PubMed |
| 6 | 40078181 | Imaging, clinical, and histopathological challenges in diagnosing retroperitoneal extraskeletal osteosarcoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/40078181 | PubMed |
| 7 | 39294748 | Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. | Mil Med Res | 2024 | https://conductscience.org/library/papers/39294748 | PubMed |
| 8 | 39290907 | Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/39290907 | PubMed |
| 9 | 35522060 | Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact. | Stat Med | 2022 | https://conductscience.org/library/papers/35522060 | PubMed |
| 10 | 32275330 | Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32275330 | PubMed |
| 11 | 12692111 | Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. | Cancer Epidemiol Biomarkers Prev | 2003 | https://conductscience.org/library/papers/12692111 | PubMed |
| 12 | 40580032 | Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021. | Cancer Control | 2025 | https://conductscience.org/library/papers/40580032 | PubMed |
| 13 | 39059750 | Global, regional, and national burden and trends analysis of malignant neoplasm of bone and articular cartilage from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021. | Bone | 2024 | https://conductscience.org/library/papers/39059750 | PubMed |
| 14 | 40670971 | Health inequality and the global burden of mesothelioma: insights from the global burden of disease study 2021. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40670971 | PubMed |
| 15 | 39720601 | Global, regional, and national epidemiology of childhood neuroblastoma (1990-2021): a statistical analysis of incidence, mortality, and DALYs. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/39720601 | PubMed |
| 16 | 39979494 | Disease burden of trachea, bronchus and lung cancer 1990-2021 and global trends projected to 2035. | Sci Rep | 2025 | https://conductscience.org/library/papers/39979494 | PubMed |
| 17 | 31565485 | Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China. | Cancer Biol Med | 2019 | https://conductscience.org/library/papers/31565485 | PubMed |
| 18 | 28988646 | Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28988646 | PubMed |
| 19 | 39762371 | An analysis of extraskeletal osteosarcoma based on the literature. | Sci Rep | 2025 | https://conductscience.org/library/papers/39762371 | PubMed |
| 20 | 32842323 | [Application of Joinpoint regression model in cancer epidemiological time trend analysis]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2020 | https://conductscience.org/library/papers/32842323 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41792370 | Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41792370 |
Source PubMed
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NF1 | 4763 | PubTator's text mining | https://conductscience.org/library/genes/4763 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| SSX2B | 727837 | PubTator's text mining | https://conductscience.org/library/genes/727837 | NCBI Gene |
| SYT1 | 6857 | PubTator's text mining | https://conductscience.org/library/genes/6857 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40971981
GET https://conductscience.org/api/papers/v1/40971981/references?page=2